Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Read the Original
This page is a summary of: Dianthin-30 or gelonin versus monomethyl auristatin E, each configured with an anti-calcitonin receptor antibody, are differentially potent in vitro in high-grade glioma cell lines derived from glioblastoma, Cancer Immunology Immunotherapy, May 2017, Springer Science + Business Media, DOI: 10.1007/s00262-017-2013-z.
You can read the full text:
The following have contributed to this page